1. COPD. World Health Organization (2017)
2. Burden of COPD. World Health Organization
3. BPCO: dati epidemiologici. Ministero della Salute (ultimo aggiornamento Novembre 2019)
4. Rogliani P. et al. Adherence to COPD treatment: Myth and reality. Respiratory Medicine (2017); 129: 117-123
5. Humenberger M et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulmonary Medicine (2018); 18:163
6. Bourbeau J and Bartlett SJ. Patient adherence in COPD. Thorax (2008); 63:831–838
7. Jardim JR and Nascimento OA. The Importance of Inhaler Adherence to Prevent COPD Exacerbations. Med. Sci. (2019), 7: 54
8. Chrystyn H. et al. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respiratory Medicine (2014); 108: 358-365
9. van der Palen J. et al. A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD. International Journal of COPD (2018);13: 2515–2523
10. Komase Y. et al. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older. International Journal of COPD (2014);9: 1365–1375
11. Grandmaison G, Grobéty T, Vaucher J, Hayoz D, Suter P. Prevalence of critical errors and insufficient peak inspiratory flow in patients hospitalized with COPD in a department of general internal medicine: a cross-sectional study. Chronic Obstr Pulm Dis. 2024; 11(4): 406-415. doi: http://doi.org/10.15326/jcopdf.2024.0505
12. Duarte-de-Araújo A et al. J. COPD: misuse of inhaler devices in clinical practice. Int J Chron Obstruct Pulmon Dis. 2019 May 30;14:1209-1217. doi: 10.2147/COPD.S178040
13. Chrystyn H et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med. 2017 Apr 3;27(1):22. doi: 10.1038/s41533-017-0016-z.